News
Zacks Investment Research on MSN13h
AstraZeneca Rides Oncology Momentum With Blockbuster and New Drugs
AstraZeneca AZN is one of the leading drugmakers in the oncology space. Oncology sales (comprising around 43% of AstraZeneca‘s total revenues) rose 18% in the second quarter of 2025, generating $6.3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback